Neuren Pharmaceuticals Limited (NEU.AX)
AUD 12.54
(-2.79%)
AUD 12.54
(-2.79%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 231.92 Million | 14.55 Million | 3.19 Million | 717 Thousand | 495 Thousand | 13.99 Million |
| Cost of Revenue | 26.75 Million | 10 Thousand | 8000.00 | 6000.00 | 4000.00 | 6.1 Million |
| Gross Profit | 205.17 Million | 14.54 Million | 3.18 Million | 711 Thousand | 491 Thousand | 7.88 Million |
| Operating Expenses | 32.69 Million | 16.13 Million | 11.42 Million | 9.52 Million | 11.56 Million | 5.03 Million |
| Selling, General and Administrative Expenses | 5.94 Million | 3.42 Million | 1.9 Million | 1.75 Million | 1.7 Million | 2.07 Million |
| Research and Development Expenses | 26.75 Million | 12.71 Million | 9.51 Million | 7.76 Million | 9.85 Million | 6.1 Million |
| Other Expenses | - | 1.38 Million | 3.59 Million | 186 Thousand | 366 Thousand | -2.51 Million |
| Cost and Expenses | 59.44 Million | 16.14 Million | 11.43 Million | 9.52 Million | 11.57 Million | 11.13 Million |
| Operating Income | 225.96 Million | -1.59 Million | -11.43 Million | -9.52 Million | -11.57 Million | 5.81 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 48.05 Million | -864 Thousand | -3.19 Million | -717 Thousand | -495 Thousand | -446 Thousand |
| Earnings before Tax | 205.12 Million | -680 Thousand | -10.99 Million | -9.91 Million | -11.31 Million | 3.07 Million |
| Net Income | 157.08 Million | 184 Thousand | -7.79 Million | -9.19 Million | -10.81 Million | 3.07 Million |
| Earnings Per Share Basic | 1.24 | 0.00 | -0.07 | -0.09 | -0.11 | 0.03 |
| Earnings Per Share Diluted | 1.20 | 0.00 | -0.07 | -0.09 | -0.11 | 0.03 |
| Weighted Average Shares Outstanding | 127.06 Million | 125.96 Million | 117.77 Million | 107.05 Million | 100.16 Million | 99.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 130.76 Million | 128.9 Million | 117.77 Million | 107.05 Million | 100.16 Million | 99.75 Million |
| Gross Margin | 0.88 | 1.00 | 1.00 | 0.99 | 0.99 | 0.56 |
| EBIT Margin | 0.86 | -0.11 | -3.57 | -13.28 | -23.37 | 0.42 |
| Profit Margin | 0.68 | 0.01 | -2.44 | -12.82 | -21.85 | 0.22 |
| EBITDA | 199.26 Million | -1.58 Million | -8.22 Million | -8.8 Million | -11.07 Million | 5.36 Million |
| Earnings Before Tax Margin | 0.97 | -0.11 | -3.58 | -13.29 | -23.38 | 0.42 |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Revenue | 24.32 Million | 231.92 Million | 168.99 Million | 62.92 Million | 14.55 Million | 14.55 Million |
| Cost of Revenue | 17.88 Million | 26.75 Million | 15.66 Million | 11.08 Million | 6000.00 | 10 Thousand |
| Gross Profit | 6.43 Million | 205.17 Million | 153.33 Million | 51.83 Million | 14.54 Million | 14.54 Million |
| Operating Expenses | 20.26 Million | 32.68 Million | 17.9 Million | 14.77 Million | 8.8 Million | 16.13 Million |
| Selling, General and Administrative Expenses | 2.37 Million | - | 2.24 Million | 3.68 Million | 704 Thousand | - |
| Research and Development Expenses | 17.88 Million | - | 15.66 Million | 11.08 Million | 8.1 Million | - |
| Other Expenses | - | 225 Thousand | - | - | - | 1.38 Million |
| Cost and Expenses | 38.15 Million | 32.69 Million | 17.91 Million | 14.78 Million | 8.81 Million | 16.14 Million |
| Operating Income | -13.82 Million | 199.22 Million | 151.08 Million | 48.14 Million | 5.74 Million | -1.59 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 3.82 Million | 48.04 Million | 46.22 Million | 1.81 Million | -864 Thousand | -864 Thousand |
| Earnings before Tax | 11.84 Million | 205.12 Million | 155.5 Million | 49.62 Million | 6.37 Million | -680 Thousand |
| Net Income | 8.01 Million | 157.08 Million | 109.27 Million | 47.8 Million | 7.23 Million | 184 Thousand |
| Earnings Per Share Basic | 0.06 | - | 0.86 | 0.38 | 0.06 | - |
| Earnings Per Share Diluted | 0.06 | - | 0.83 | 0.37 | 0.06 | - |
| Weighted Average Shares Outstanding | 130.76 Million | 127.06 Million | 127.26 Million | 126.33 Million | 125.96 Million | 125.96 Million |
| Weighted Average Shares Outstanding (Diluted) | 130.81 Million | 130.76 Million | 131.08 Million | 130.04 Million | 126.03 Million | 128.9 Million |
| Gross Margin | 0.26 | 0.88 | 0.91 | 0.82 | 1.00 | 1.00 |
| EBIT Margin | 0.17 | - | 0.89 | 0.77 | 0.39 | - |
| Profit Margin | 0.33 | 0.68 | 0.65 | 0.76 | 0.50 | 0.01 |
| EBITDA | 4.07 Million | - | 151.09 Million | 48.14 Million | 5.74 Million | - |
| Earnings Before Tax Margin | -0.57 | 0.86 | 0.89 | 0.77 | 0.39 | -0.11 |
3712
KDKCF
0I4Q
EEFT
KUWERIN
4238